Google’s Biotech Investment In Brin’s Wife’s Company, 23andMe
Raising some eyebrows this morning is Google’s investment in a biotech firm called 23andMe, which states as its mission to: “help you make sense of your own genetic information . . . [and] put your genome into the larger context of human commonality and diversity.”
Anne Wojcicki, Google cofounder Sergey Brin’s new wife, is a cofounder of 23andMe. Esther Dyson is a board member. According to regulatory filings, Google took a minority stake in the company for $3.9 million. Here are some more reports from SF Gate and the NY Times.
Joining Google in the series A investment round were New Enterprise Associates, MDV-Mohr Davidow Ventures and Genentech.
Some opinions expressed in this article may be those of a guest author and not necessarily Search Engine Land. Staff authors are listed here.
(Some images used under license from Shutterstock.com.)
Discover what's up in the business of marketing each Friday.